{
    "clinical_study": {
        "@rank": "40204", 
        "arm_group": [
            {
                "arm_group_label": "Drainage Group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "early placental drainage plus cord traction"
            }, 
            {
                "arm_group_label": "Controlled Group", 
                "arm_group_type": "No Intervention", 
                "description": "spontaneous removal placenta"
            }
        ], 
        "brief_summary": {
            "textblock": "To determine whether early placental drainage plus cord traction reduces the incidences of\n      manual removal and blood loss, and to determine the risk factors associated with blood loss\n      after delivery."
        }, 
        "brief_title": "The Influence of Placental Drainage of Management of the Third Stage of Labor:a Randomized Controlled Study", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Postpartum Haemorrhage", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Postpartum Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. greater than 37 gestational weeks\n\n          2. single pregnancy\n\n          3. vaginal delivery\n\n          4. estimated fetal weight 2500-4500 gr.\n\n        Exclusion Criteria:\n\n          1. PPROM\n\n          2. 37 or lower gestational week\n\n          3. multiple pregnancy\n\n          4. grand multipar\u0131ty (greater than 5)\n\n          5. coagulation defects (HELLP, ablation placenta, previa, pre-eclampsia)\n\n          6. a history of any bleeding during pregnancy\n\n          7. caesarean delivery or any uterine scar\n\n          8. a history of postpartum haemorrhage\n\n          9. hydramnios\n\n         10. known uterine anomalies\n\n         11. suspected abnormal placentation (accreta, increta, or percreta)\n\n         12. prepartum hemoglobin concentration less than 8 g/dL\n\n         13. history of anticoagulant drugs and prolongation of the first stage of labor longer\n             than 15 hours"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "44 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "485", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01931423", 
            "org_study_id": "A\u015f\u0131c\u0131o\u011flu-06"
        }, 
        "intervention": {
            "arm_group_label": "Drainage Group", 
            "intervention_name": "Placental cord drainage", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "\u0130stanbul", 
                    "country": "Turkey", 
                    "state": "\u015ei\u015eL\u0130", 
                    "zip": "32744"
                }, 
                "name": "Osman A\u015f\u0131c\u0131o\u011flu"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "T.C.S.B. \u015ei\u015fli Etfal Research Hospital", 
            "last_name": "Osman A\u015f\u0131c\u0131o\u011flu, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "postpartum blood loss", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01931423"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Istanbul Bakirkoy Maternity and Children Diseases Hospital", 
            "investigator_full_name": "Osman A\u015f\u0131c\u0131o\u011flu", 
            "investigator_title": "M.D. Obstetric and Gynecology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Istanbul Bakirkoy Maternity and Children Diseases Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Istanbul Bakirkoy Maternity and Children Diseases Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}